David J. Park, MD

Articles by David J. Park, MD

A panel of 4 experts on multiple myeloma

Collaborative Education for CAR T-Cell Therapy

ByAmrita Y. Krishnan, MD,Saad Z. Usmani, MD, MBA, FACP,David J. Park, MD,Sanjay Sharma, MD

July 10th 2024

The panel concludes its discussion with insights on practices for educating health care teams on CAR T-cell therapy administration, highlighting the evolving role of advanced practice providers.

David J. Park, MD

Articles by David J. Park, MD

Collaborative Education for CAR T-Cell Therapy

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC

Achieving a “Functional Cure” With Multiple Myeloma Therapy